Single versus recurrent depression history: differentiating risk factors among current US smokers
- PMID: 20074868
- PMCID: PMC2890270
- DOI: 10.1016/j.drugalcdep.2009.12.020
Single versus recurrent depression history: differentiating risk factors among current US smokers
Abstract
Introduction: The strong relationship between persistent tobacco use and Major Depressive Disorder (MDD) has motivated clinical trials of specialized treatments targeting smokers with a history of MDD. Meta-analyses suggest positive responses to specialized treatments have been observed consistently among smokers with history of recurrent rather than a single episode of MDD. Approximately 15% of current US smokers have a history of recurrent MDD. Little is known about the risk factors that contribute to persistent smoking and differentiate these at-risk smokers, US.
Methods: The National Comorbidity Survey - Replication (NCS-R) included a survey of 1560 smokers participants aged 18 and older in the United States. Lifetime history of MDD was categorized according to chronicity: no history (No MDD), single episode (MDD-S) and recurrent depression (MDD-R). The relationship between the chronicity of MDD, smoking characteristics, cessation history, nicotine dependence, comorbidity with psychiatric disorders, and current functional impairments were examined.
Results: MDD-R smokers reported fewer lifetime cessation efforts, smoked more cigarettes, had higher levels of nicotine dependence, had higher rates of comorbid psychiatric disorders and greater functional impairment than smokers with No MDD. MDD-S smokers were not consistently distinguished from No MDD smokers on cessation attempts, level of daily smoking, nicotine dependence or functional impairment indices.
Conclusions: The study highlights the importance of chronicity when characterizing depression-related risk of persistent smoking behavior. Although, clinical trials suggest MDD-R smokers specifically benefit from specialized behavioral treatments, these services are not widely available and more efforts are needed to engage MDD-R smokers in efficacious treatments.
Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Motives for Smoking in Those With PTSD, Depression, and No Psychiatric Disorder.J Dual Diagn. 2020 Jul-Sep;16(3):285-291. doi: 10.1080/15504263.2020.1759846. Epub 2020 May 12. J Dual Diagn. 2020. PMID: 32393117 Free PMC article.
-
Smoking and major depressive disorder in Chinese women.PLoS One. 2014 Sep 2;9(9):e106287. doi: 10.1371/journal.pone.0106287. eCollection 2014. PLoS One. 2014. PMID: 25180682 Free PMC article.
-
The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population.Addiction. 2012 Oct;107(10):1847-56. doi: 10.1111/j.1360-0443.2012.03889.x. Epub 2012 May 17. Addiction. 2012. PMID: 22429388 Free PMC article.
-
Depression during tobacco abstinence.Nicotine Tob Res. 2007 Apr;9(4):443-6. doi: 10.1080/14622200701243185. Nicotine Tob Res. 2007. PMID: 17454698 Review.
-
Effectiveness of pharmacological or psychological interventions for smoking cessation in smokers with major depression or depressive symptoms: A systematic review of the literature.Subst Abus. 2018;39(3):289-306. doi: 10.1080/08897077.2018.1439802. Epub 2018 Apr 5. Subst Abus. 2018. PMID: 29436984
Cited by
-
Smoking cessation and reduction in people with chronic mental illness.BMJ. 2015 Sep 21;351:h4065. doi: 10.1136/bmj.h4065. BMJ. 2015. PMID: 26391240 Free PMC article. Review.
-
Serum L-selectin levels as predictive markers for chronic major depressive disorder progression.Ann Gen Psychiatry. 2024 Oct 16;23(1):37. doi: 10.1186/s12991-024-00522-0. Ann Gen Psychiatry. 2024. PMID: 39415236 Free PMC article.
-
Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.J Clin Psychopharmacol. 2019 Mar/Apr;39(2):108-116. doi: 10.1097/JCP.0000000000001015. J Clin Psychopharmacol. 2019. PMID: 30811371 Free PMC article. Clinical Trial.
-
Depressive symptoms among heavy cigarette smokers: the influence of daily rate, gender, and race.Nicotine Tob Res. 2013 Oct;15(10):1714-21. doi: 10.1093/ntr/ntt047. Epub 2013 Apr 8. Nicotine Tob Res. 2013. PMID: 23569006 Free PMC article.
-
The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial.Depress Anxiety. 2022 May;39(5):429-440. doi: 10.1002/da.23259. Depress Anxiety. 2022. PMID: 35535436 Free PMC article. Clinical Trial.
References
-
- Andrade L, Caraveo-Anduaga JJ, Berglund P, Bijl RV, De Graaf R, Vollebergh W, Dragomirecka E, Kohn R, Keller M, Kessler RC, Kawakami N, Kilic C, Offord D, Ustun TB, Wittchen HU. The epidemiology of major depressive episodes: Results from the international consortium of psychiatric epidemiology (ICPE) surveys. Int J Methods Psychiatr Res. 2003;12(1):3–21. - PMC - PubMed
-
- Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: Findings from an epidemiologic study of young adults. Am J Psychiatry. 1992;149(4):464–469. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources